Target intelligence / Profile preview

FKBP prolyl isomerase 4 pseudogene 1 (FKBP4P1)

Target: FKBP4P1

Overview

FKBP prolyl isomerase 4 pseudogene 1 (FKBP4P1) is a noncoding genomic element classified as a pseudogene. It shares sequence similarity with the functional FKBP4 gene but does not encode a protein and has no known biological, clinical, or therapeutic significance[6][4]. FKBP4P1 is not considered a valid drug target or biomarker and should not be confused with the active FKBP4 (FKBP52), which is a member of the immunophilin protein family with relevant molecular functions and disease associations[1][2][9][10]. If you require information on FKBP4 (the functional protein), please clarify, as FKBP4P1 only refers to a pseudogene[6][4].

Other names: FKBP4P1FKBP prolyl isomerase 4 pseudogene 1

Mechanism of action

none (not a drug target)

Beyond the preview

Go deeper on FKBP prolyl isomerase 4 pseudogene 1 (FKBP4P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FKBP prolyl isomerase 4 pseudogene 1 (FKBP4P1).

Explore the full profile